| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/15/2004 | WO2004005338A1 Secreted peptides |
| 01/15/2004 | WO2004005337A1 Phosphoinositolglycan (pig)-binding protein from adipocytes |
| 01/15/2004 | WO2004005336A2 β-SHEET BREAKING PEPTIDES |
| 01/15/2004 | WO2004005335A2 Multimerised growth hormone fusion proteins |
| 01/15/2004 | WO2004005334A2 Nucleic acid molecule encoding an allergen preprotein of a mite of genus dermatophagoides or euroglyphus and use thereof for protecting said allergen in plants |
| 01/15/2004 | WO2004005333A1 Use of hepatitis c virus (hcv) p7 protein |
| 01/15/2004 | WO2004005332A2 Secreted peptides |
| 01/15/2004 | WO2004005331A2 Peptides derived from pep133 (g1p3, 6-16) |
| 01/15/2004 | WO2004005329A1 Plant peptide with antimicrobial activity |
| 01/15/2004 | WO2004005323A2 Affinity small molecules for the epo receptor |
| 01/15/2004 | WO2004005322A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | WO2004005316A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
| 01/15/2004 | WO2004005221A2 Benzoate- and anthranilate-inducible promoters |
| 01/15/2004 | WO2004004766A1 MP53S AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 01/15/2004 | WO2004004763A2 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 01/15/2004 | WO2004004761A2 Adjuvant viral particle |
| 01/15/2004 | WO2004004760A1 Vaccine for feline infectious peritonitis |
| 01/15/2004 | WO2004004742A1 Improved gm-csf nucleic acid sequences |
| 01/15/2004 | WO2004004663A2 Compositions and methods for ligament growth and repair |
| 01/15/2004 | WO2004004662A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2004 | WO2004004656A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 01/15/2004 | WO2004004652A2 Mitotic kinesin binding site |
| 01/15/2004 | WO2004004649A2 Compositions and methods for the treatment of immune related diseases |
| 01/15/2004 | WO2004004642A2 TCELL TOLERANCE AND MODULATION OF AUTOIMMUNITY BY CD8α-CD4+ DENDRITIC CELLS |
| 01/15/2004 | WO2004004630A2 Osteoinductive biomaterials |
| 01/15/2004 | WO2004004495A1 Virulent phages to control listeria monocytogenes in foodstuffs and in food processing plants |
| 01/15/2004 | WO2004004455A2 Composition and method for stabilising biomolecules |
| 01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | WO2004004447A2 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003089591A3 Method of production of soluble and functional large eukaryotic proteins |
| 01/15/2004 | WO2003089572A3 Essential and important genes of pseudomonas aeroginosa and the use thereof to design or identify antibacterial agents |
| 01/15/2004 | WO2003087337A3 Vascularized human skin equivalent |
| 01/15/2004 | WO2003086272A3 Ultrapure transferrin for pharmaceutical compositions |
| 01/15/2004 | WO2003080800A3 Prevention and treatment of disease using angiogenesis-and/or tumor antigens |
| 01/15/2004 | WO2003078456A3 Human diabetes-mediating proteins |
| 01/15/2004 | WO2003074667A3 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells |
| 01/15/2004 | WO2003063904A3 Tissue adhesion formation control |
| 01/15/2004 | WO2003061587A3 USE OF TGF-β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION |
| 01/15/2004 | WO2003060072A3 Recombinant polypeptides |
| 01/15/2004 | WO2003057847A8 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 01/15/2004 | WO2003054008A3 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 01/15/2004 | WO2003045995A3 Cell culture process |
| 01/15/2004 | WO2003040169A3 Human monoclonal antibodies to dendritic cells |
| 01/15/2004 | WO2003037251A9 Hivgp120-induced bob/gpr15 activation |
| 01/15/2004 | WO2003020019A3 Methods and compositions for pearl oyster cultivation |
| 01/15/2004 | WO2003012048A3 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002095032A3 Methods and compositions of human proteins and uses thereof. |
| 01/15/2004 | WO2002086093A3 Methods of using a hyaluronan receptor |
| 01/15/2004 | WO2002078526A3 Cancer-testis antigens |
| 01/15/2004 | WO2002072607A3 Soluble heterodimeric cytokine receptor |
| 01/15/2004 | WO2002072023A3 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
| 01/15/2004 | WO2002061037B1 Administration of nucleic acid sequence to female animal |
| 01/15/2004 | WO2002060935A8 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/15/2004 | WO2002057304A3 Secretory molecules |
| 01/15/2004 | WO2002046364A8 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/15/2004 | WO2002042777A3 Modulation of the interaction between evh1 domains |
| 01/15/2004 | US20040010817 Comprises enzymatic polypeptide for synthesis of fatty acids for use in industrial lubricants, plasticizers and surfactants; vegetable oils |
| 01/15/2004 | US20040010815 Identification and characterization of plant genes |
| 01/15/2004 | US20040010812 Comprises nucleotide sequences coding receptor for hyaluronic acid mediated motility (RHAMM) for diagnosing, preventing, prognosing and treating tumor disorders; gene expression inhibition; antisense therapy |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010135 Comprises nucleotide sequences coding polypeptide for preventing and viral infection; viricides |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010132 53 human secreted proteins |
| 01/15/2004 | US20040010131 Gramnegative bacterial nucleotide sequences for diagnosing infection and generating disease resistant plants |
| 01/15/2004 | US20040010125 Human immunodeficiency viral glycoprotein (HIV) for diagnosis, prevention and treatment of viral infection; genetic vaccines |
| 01/15/2004 | US20040010123 Novel cocoa albumin and its use in the production of cocoa and chocolate flavor |
| 01/15/2004 | US20040010122 Treating animal skin tissues to extract and fractionate collagen-rich proteinaceous materials for use as meat replacer, texturizer, binder/filler, stabilizer and/or protective colliods in food processing |
| 01/15/2004 | US20040010121 Comprises nucleotide sequences coding polypeptide for diagnosis and treatment of cell proliferative, autoimmune and infectious disorders; antitumor agents |
| 01/15/2004 | US20040010120 Novel polypeptides and nucleic acids encoding same |
| 01/15/2004 | US20040010119 Novel proteins and nucleic acids encoding same |
| 01/15/2004 | US20040010118 Novel proteins and nucleic acids encoding same |
| 01/15/2004 | US20040010117 Comprises streptococcal protein which inhibits hemolysis (SIC) for preventing and treating glomreulonephritis and rheumatic fever; genetic vaccines |
| 01/15/2004 | US20040010116 Comprises peptide for treating cancer, nervous system, autoimmune and arthritic disorders; high throughput assay; epitope mapping; drug design |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/15/2004 | US20040009945 A gene coding for an anthrax protein is cloned into a VEE virus vector to produce a self-replicating RNA molecule, a replicon, that encodes its own replicase and transcription functions |
| 01/15/2004 | US20040009940 Gene delivery formulations and methods for treatment of ischemic conditions |
| 01/15/2004 | US20040009939 Methods of enhancing immune induction involving MDA-7 |
| 01/15/2004 | US20040009934 GM-CSF nucleic acid sequences |
| 01/15/2004 | US20040009921 Inhibiting the proliferation of a eukaryotic cell whose growth is stimulated by beta-catenin-mediated gene transcription by administering a non-endogenous source of RXR nuclear receptor protein, and an agonist of the protein |
| 01/15/2004 | US20040009920 Comprising angiogenesis inhibitors and RGD-containing plasma adhesion proteins in a pharmaceutical carrier. |
| 01/15/2004 | US20040009916 Purified BMP-2 and BMP-4 proteins used in the treatment of bone and cartilage defects and in wound healing and related tissue repair. |
| 01/15/2004 | US20040009915 Polynucleotides encoding a novel intracellular chloride channel-related polypeptide |
| 01/15/2004 | US20040009914 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 01/15/2004 | US20040009913 Detecting, identifying and screening for srf signal transduction pathway elements for diagnosis |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |
| 01/15/2004 | US20040009907 Nucleic acids encoding cytoplasmic, nuclear, membrane bound, and secreted polypeptides, as well as vectors, host cells, antibodies, and recombinant methods for production |
| 01/15/2004 | US20040009905 Templates consist of cyclized peptides containing at least two residues in said cyclized peptide are joined by a naphthyl ring; and having bonded to it a linear peptide |
| 01/15/2004 | US20040009904 APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 01/15/2004 | US20040009902 CTP extended erythropoietin |
| 01/15/2004 | US20040009901 Identifying and administering an agent that enhances NADPH oxidase activity; diagnosing an autoimmune condition accompanied by NADPH oxidase deficiency |
| 01/15/2004 | US20040009897 Stabilized synthetic immunogen delivery system |
| 01/15/2004 | US20040009604 Plasmid which codes envelop fusogenic membrane protein for treating cell proliferative disorders; antitumor agents; immunotherapy; gene therapy |
| 01/15/2004 | US20040009603 Antiviral vectors |
| 01/15/2004 | US20040009591 Keratinocytes expressing exogenous angiogenic growth factors |
| 01/15/2004 | US20040009571 Dimerization interface of signal transducer and activator of transcription (STAT) proteins |
| 01/15/2004 | US20040009568 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 01/15/2004 | US20040009559 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 01/15/2004 | US20040009558 Ligand binding pocket peptide fragment of the estrogen-related receptor 3 (ERR3) and uses thereof |